BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 18976753)

  • 21. Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners.
    Guida M; Di Spiezio Sardo A; Bramante S; Sparice S; Acunzo G; Tommaselli GA; Di Carlo C; Pellicano M; Greco E; Nappi C
    Hum Reprod; 2005 Apr; 20(4):1100-6. PubMed ID: 15608030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis.
    Vercellini P; Barbara G; Somigliana E; Bianchi S; Abbiati A; Fedele L
    Fertil Steril; 2010 May; 93(7):2150-61. PubMed ID: 19328469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined hormonal contraception in cycles artificially extended].
    Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
    Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
    Victor I; Fink RA
    Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual function in first-time contraceptive ring and contraceptive patch users.
    Gracia CR; Sammel MD; Charlesworth S; Lin H; Barnhart KT; Creinin MD
    Fertil Steril; 2010 Jan; 93(1):21-8. PubMed ID: 18976753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in contraception: new technology.
    Linn ES
    Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring.
    Nguyen BT; Jensen JT
    Expert Opin Drug Saf; 2014 Oct; 13(10):1423-30. PubMed ID: 25106828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
    Roumen FJ; Mishell DR
    Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):415-27. PubMed ID: 23113828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal ring contraception.
    Kerns J; Darney P
    Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High acceptability and satisfaction with NuvaRing use.
    Szarewski A
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():31-6; discussion 37-9. PubMed ID: 12659400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The vaginal ring (NuvaRing®) for contraception in adolescent women.
    Bitzer J
    Gynecol Endocrinol; 2012 Feb; 28(2):125-9. PubMed ID: 21615237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contraceptive vaginal ring.
    Edwardson J; Jamshidi R
    Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choice of contraceptives.
    Med Lett Drugs Ther; 2015 Sep; 57(1477):127-32. PubMed ID: 26353044
    [No Abstract]   [Full Text] [Related]  

  • 35. The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
    Wagner MS; Arias RD; Nucatola DL
    Expert Opin Pharmacother; 2007 Aug; 8(11):1769-77. PubMed ID: 17685892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis and new contraception frontiers with combined vaginal rings.
    Barriga Pooley P; Von Hoveling A; Galán G; López Berroa J
    Gynecol Endocrinol; 2020 Jun; 36(6):475-478. PubMed ID: 32091277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transurethral placement of vaginal contraceptive device in a patient with neurogenic bladder: a case report and review of the literature.
    Ehdaie B; Mason MD; Peters CA; Corbett ST
    J Pediatr Urol; 2013 Apr; 9(2):e107-10. PubMed ID: 23219318
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.